Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Isotrexin gel
1306010I0BDAAAC
|
Isotrexin | Erythromycin | Skin | 18 |
|
Dermacort hydrocortisone 0.1% cream
1304000V0BNAAAW
|
Dermacort | Hydrocortisone | Skin | 17 |
|
Solacutan 3% gel
1308010W0BCAAAA
|
Solacutan | Diclofenac sodium | Skin | 17 |
|
Erythromycin 4% gel
1306010I0AAAEAE
|
Erythromycin (Topical) | Erythromycin | Skin | 16 |
|
Lidocaine 0.5% gel
1303000Q0AAAAAA
|
Lidocaine hydrochloride (Topical Local Anaesthetic) | Lidocaine hydrochloride | Skin | 16 |
|
Neotigason 25mg capsules
1305020A0BBAAAA
|
Neotigason | Acitretin | Skin | 16 |
|
Reflectant sunscreen beige (Dundee formula) cream
1308010U0AAAJAJ
|
Titanium dioxide (Sunscreen) | Titanium dioxide | Skin | 16 |
|
Videne 10% alcoholic tincture
1311040K0BBABAF
|
Videne | Iodine compounds | Skin | 16 |
|
Allergenics Skin lotion
130201000BBJCA0
|
Proprietary compound emollients | Other emollient preparations | Skin | 15 |
|
Dithranol 2% cream
1305020F0AADBDB
|
Dithranol (Topical) | Dithranol | Skin | 15 |
|
Haelan 4micrograms/square cm tape 7.5cm
1304000T0BBAGCC
|
Haelan | Fludroxycortide | Skin | 15 |
|
Sodium hypochlorite 2% solution
1311040T0AABABA
|
Sodium hypochlorite (Topical) | Sodium hypochlorite | Skin | 15 |
|
Zinc oxide 12.5% / Dimeticone 1.04% spray
1302020D0AAAGAG
|
Dimeticone (Barrier) | Dimeticone (Barrier) | Skin | 15 |
|
Betamethasone valerate 0.1% ointment 25% in Coal tar paste
1304000F0AACSCS
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 14 |
|
Generic Timodine cream
1304000V0AACBCB
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 14 |
|
Hydrocortisone Bite and Sting Relief 1% cream
1304000V0CWAAAD
|
Galpharm (Hydrocortisone) | Hydrocortisone | Skin | 14 |
|
Nystatin 100,000units/g cream
1310020U0AAAAAA
|
Nystatin (Topical) | Nystatin | Skin | 14 |
|
Phenol 1.2% / Chlorhexidine gluconate 0.25% cream
1310050P0AAADAD
|
Phenol (Topical) | Phenol | Skin | 14 |
|
Salicylic acid 2% / Sulfur 2% in Aqueous cream
1306010T0AAAUAU
|
Sulfur (Topical) | Sulfur | Skin | 14 |
|
Spirigel alcohol hand gel
1311010A0BDAAAK
|
Spirigel | Alcohol | Skin | 14 |
|
BioBag 300 6cm x 12cm dressing kit
1311070S0BDABAA
|
BioBag | Ster larvae | Skin | 13 |
|
BioBag 400 10cm x 10cm dressing kit
1311070S0BDAAAA
|
BioBag | Ster larvae | Skin | 13 |
|
Delph sun lotion SPF 50+
130801000BBPIA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 13 |
|
Canesten Bifonazole Once Daily 1% cream
1310020E0BCAAAA
|
Canesten (Athletes foot) | Bifonazole | Skin | 12 |
|
Cetaphil PRO Itch Prone Skin body wash
130501000BBBLA0
|
Proprietary compound preparation BNF 1305010 | Other eczema preparations | Skin | 12 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.